3-FA

3-FA (CAS 1626-71-7) is entry 15 of China's non-medical narcotic and psychotropic catalogue and is subject to the current regulation's prohibition on production, operation, use, storage and transport, with only regulated experimental research permitted. The 2025 consolidated catalogue repealed the former 2015 supplemental catalogue, and the 2026-07-01 amendment adds other substances; an official police directory updated in 2026 still displays 3-FA entry 15. The classification is nationwide in China.

3-FA is expressly named in current Annex IV of Decree 543/2008 as amended by 651/2026, and Narcotics Act Section 5 prohibits ordinary possession, use, handling, trade, distribution, transport, import/export, manufacture and production of narcotic drugs. The Act preserves only narrowly defined medicinal, research and control-purpose exceptions. This classification applies nationwide in Finland and has no subnational exception.

The substance is 1-(3-fluorophenyl)propan-2-amine (3-fluoroamphetamine). 3-FA is not an individually named entry in Medsafe's current medicine-classification materials; the applicable basis is the Misuse of Drugs Act 1975 Schedule 3 Part 7 generic amphetamine-analogue provision applied to the molecule's alpha-methylphenethylamine nucleus and fluoro phenyl substitution. This is a Class C controlled-drug classification for ordinary non-exempt handling, not a separate listing of the trivial name in the schedule. Customs and Medsafe guidance confirm that import, supply and administration require the applicable licence, approval or statutory exemption; no unrestricted consumer or recreational exception is described in the guidance. The classification applies nationwide in New Zealand, with no stated subnational exception.

3-FA is structurally captured by the 2015/7238 Turkish Annex as an alpha-methyl, meta-fluoro derivative of the defined 2-phenylethylamine scaffold. The decision places covered compounds under Law No. 2313, while Turkey's official National Police report describes the 2015 Generic Classification System as covering most NPS before entry into the country. TCK 188 prohibits unlicensed manufacture, import/export and trafficking-related domestic handling, while TCK 191 addresses personal-use purchase, possession and use. Because the criminal provisions distinguish trafficking-related possession from personal-use conduct and preserve licensing/statutory rules, not every form of possession is prohibited. Law No. 7445's 2023 amendment adds amphetamine derivatives to the TCK 188(4)(a) aggravation list but is not the source of the underlying schedule classification. The legal framework provides no general recreational or consumer exception; any medicinal, scientific, licensing or case-specific defenses are governed by applicable licensing and statutory rules.

1-(3-fluorophenyl)propan-2-amine (3-fluoroamphetamine) is a Class A controlled drug. The precise legal basis is the current generic ring-substituted phenethylamine clause in Schedule 2 Part I paragraph 1(c), rather than a separately named 3-FA entry or an undefined analogue principle. The matching Schedule 1 paragraph 1(d) in the Misuse of Drugs Regulations 2001 confirms the regulatory schedule. Sections 3, 4 and 5 make the ordinary import/export, production, supply and possession restrictions applicable subject to the Act's regulations, licences and statutory exceptions; Schedule 4 confirms the severe Class A maximum punishments. The classification applies to the stated molecular identity and ordinary non-exempt handling.

State-law controls apply in Illinois and Nevada. Illinois expressly places 3-fluoroamphetamine in Schedule I, and Nevada's regulation expressly includes 3-fluoroamphetamine and 3-FA. Florida's statute lists Fluoroamphetamine but does not specify the positional isomer and therefore does not expressly classify 3-FA. The DEA reference list does not include 3-FA, and 3-FA may be subject to analogue controls under 21 U.S.C. §§ 802(32) and 813. Federal classification and controls in other states remain unresolved.

Under the current generic Anlage 1 Nr. 1 structure, 3-FA means 1-(3-fluorophenyl)propan-2-amine and is covered as a new psychoactive substance unless the particular substance is independently a BtMG narcotic. Section 3 prohibits possession and the other listed handling, but § 4's criminal provisions are narrower: manufacture and movement into Germany are criminalized there when done for placing into commerce, while trade, placing into commerce and administration are independently listed; simple possession is not itself listed in § 4. The substance is controlled but not ordinarily legal for consumers; it is neither unscheduled nor prohibited in the sense of a BtMG possession crime. The official BtMG Annex I–III tables contain distinct entries for 4-FA and 3-FMA. This conclusion is limited to the stated 3-FA identity and ordinary non-exempt handling.

The current Fedlex consolidation expressly names 3-FA as 1-(3-Fluorphenyl)propan-2-amin. BetmVV-EDI Article 1(2)(a) treats substances listed in Annexes 1–6 as controlled substances and Article 2(2) places Verzeichnis e in Annex 6. BetmKV Article 3(2)(e) subjects Verzeichnis-e entries to the control measures applicable to Verzeichnis-a narcotics, Article 5(2) assigns operating permits for handling Verzeichnis-e substances to the EDI, and Article 11(1) requires an operating permit for listed handling activities including manufacture, obtaining, brokering, import/export, supply and trade. BetmG Article 7(1) requires EDI authorization and compliance with its conditions for cultivating, manufacturing, importing, exporting, storing, using or placing Article 7 materials/products into circulation; Article 20(1)(c) provides up to three years' imprisonment or a monetary penalty for specified unauthorized conduct involving Article 7 substances and products. Item 13 contains no separate consumer or industrial exception. This is a permit-based classification, not an assertion that 3-FA is in Verzeichnis d or that every possible act is categorically prohibited.